BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 23, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

BSX CEO touts pipeline, future growth opportunities

Jan. 13, 2011
By Omar Ford

CEO discusses success, emerging overseas market

Jan. 11, 2011
By Omar Ford

Deals roundup: Hologic reports acquisition of Interlace for $125 million

Jan. 10, 2011
By Omar Ford
Hologic (Bedford, Massachusetts) is wasting little time this year expanding its product offerings through acquisitions. Just barely a week into 2011 and the firm is reporting that it has acquired Interlace Medical (Framingham, Massachusetts) – a privately held company, that develops the hysteroscopic tissue removal system MyoSure. (Medical Device Daily)
Read More

Financings roundup: Echo Therapeutics brings in nearly $5 million in funding

Jan. 7, 2011
By Omar Ford

Study: patients who don't meet criteria for ICD at greater risk

Jan. 6, 2011
By Omar Ford
According to a study published in the Jan. 5 issue of the Journal of the American Medical Association (JAMA) some patients who don't meet the criteria for implantable cardioverter-defibrillators (ICDs) have the devices implanted anyway, and could be at serious risk. (Medical Device Daily)
Read More

Veridex, MGH in partnership to develop next gen CTC test

Jan. 4, 2011
By Omar Ford
A new collaboration between Massachusetts General Hospital (MGH; Boston) and Veridex (Raritan, New Jersey), a Johnson & Johnson (J&J; New Brunswick, New Jersey) company, has been initiated to develop a circulating tumor cell (CTC) technology for capturing, counting and characterizing tumor cells found in patients' blood. (Medical Device Daily)
Read More

Cook's STABLE results could pave way for FDA approval

Dec. 27, 2010
By Omar Ford
Cook Medical (Bloomington, Indiana) could be making tremendous headway in obtaining FDA approval for its Zenith Dissection endovascular system, which is designed for the treatment of Type B aortic dissection. The med-tech company reported positive data from the STABLE clinical trial evaluating the application, which is comprised of a proximal endograft and a distal uncovered stent. (Medical Device Daily)
Read More

Lap-Band changes game or gastric bypass market

Dec. 23, 2010
By Omar Ford

Arthrosurface develops HemiCAP BIO implant

Dec. 21, 2010
By Omar Ford
It doesn't make sense to tear up an entire road when there's one patch of it that's damaged, nor does it make sense to replace a whole knee when the joint can be salvaged with one implant. That's the logic behind Arthrosurface's (Franklin, Tennessee) HemiCap platform technology, which is now aimed at providing a more biological solution for joint preservation. (Medical Device Daily)
Read More

Researchers find 'arm' could restore movement in patients

Dec. 20, 2010
By Omar Ford
Paralyzed patients being able to move objects with the power of their mind might not be such a foreign concept for much longer. A new study from the University of Chicago found that the performance of a brain-machine interface application designed to help paralyzed subjects move objects with their thoughts is improved with the addition of a robotic arm providing sensory feedback. (Medical Device Daily)
Read More
Previous 1 2 … 162 163 164 165 166 167 168 169 170 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • Pill in immersive interface

    New mechanism of action identified for QC-6352

    BioWorld Science
    QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing